Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.verified

VNDA

Price:

$5.2

Market Cap:

$307.28M

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule ...[Read more]

Industry

Biotechnology

IPO Date

2006-04-12

Stock Exchange

NASDAQ

Ticker

VNDA

The ROE as of December 2025 (TTM) for Vanda Pharmaceuticals Inc. (VNDA) is -16.82%

According to Vanda Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -16.82%. This represents a change of 293.00% compared to the average of -4.28% of the last 4 quarters.

Vanda Pharmaceuticals Inc. (VNDA) Historical ROE (quarterly & annually)

How has VNDA ROE performed in the past?

The mean historical ROE of Vanda Pharmaceuticals Inc. over the last ten years is -0.84%. The current -16.82% ROE has changed 1.90% with respect to the historical average. Over the past ten years (40 quarters), VNDA's ROE was at its highest in in the September 2019 quarter at 25.05%. The ROE was at its lowest in in the December 2015 quarter at -11.12%.

Quarterly (TTM)
Annual

Average

-0.84%

Median

0.83%

Minimum

-29.97%

Maximum

28.12%

Vanda Pharmaceuticals Inc. (VNDA) ROE by Quarter and Year

Discovering the peaks and valleys of Vanda Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 207.23%

Maximum Annual ROE = 28.12%

Minimum Annual Increase = -862.19%

Minimum Annual ROE = -29.97%

Quarterly (TTM)
Annual
YearROEChange
2024-3.51%-862.19%
20230.46%-61.32%
20221.19%-81.87%
20216.57%27.52%
20205.15%-81.69%
201928.12%207.23%
20189.15%-177.25%
2017-11.85%-13.60%
2016-13.71%-54.24%
2015-29.97%-338.74%

Vanda Pharmaceuticals Inc. (VNDA) Average ROE

How has VNDA ROE performed in the past?

The current ROE of Vanda Pharmaceuticals Inc. (VNDA) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.62%

5-year avg

1.97%

10-year avg

-0.84%

Vanda Pharmaceuticals Inc. (VNDA) ROE vs. Peers

How is VNDA’s ROE compared to its peers?

Vanda Pharmaceuticals Inc.’s ROE is greater than Achieve Life Sciences, Inc. (-196.68%), greater than Entrada Therapeutics, Inc. (-26.42%), less than Humacyte, Inc. (449.27%), greater than Voyager Therapeutics, Inc. (-48.94%), greater than Atea Pharmaceuticals, Inc. (-32.55%), greater than Arcturus Therapeutics Holdings Inc. (-21.51%), greater than Allogene Therapeutics, Inc. (-57.79%), greater than Sagimet Biosciences Inc. (-42.39%), greater than Immuneering Corporation (-146.28%), greater than Capricor Therapeutics, Inc. (-62.71%),

Build a custom stock screener for Vanda Pharmaceuticals Inc. (VNDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vanda Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vanda Pharmaceuticals Inc. (VNDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vanda Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Vanda Pharmaceuticals Inc.'s ROE?

How is the ROE calculated for Vanda Pharmaceuticals Inc. (VNDA)?

What is the highest ROE for Vanda Pharmaceuticals Inc. (VNDA)?

What is the 3-year average ROE for Vanda Pharmaceuticals Inc. (VNDA)?

What is the 5-year average ROE for Vanda Pharmaceuticals Inc. (VNDA)?

How does the current ROE for Vanda Pharmaceuticals Inc. (VNDA) compare to its historical average?